Company profile: Novoheart
1.1 - Company Overview
Company description
- Provider of stem cell and bioengineering platforms and services for cardiac drug discovery, including the MyHeart/mini-Heart Platform of engineered human cardiomyocyte tissues for assessing cardiac functional outputs in pre-clinical and clinical trials; the Human Heart-in-a-Jar (hvCOC); hvCAS for electrophysiology, arrhythmia, contractility and pressure-volume; the mini-Life multi-organ system; and custom drug discovery, cardiotoxicity screening, disease modeling, efficacy and dose titration.
Products and services
- Drug Discovery Services: Delivers a custom-engineered service suite for pharmaceutical development, covering drug discovery, cardiotoxicity screening, disease modeling, efficacy studies, and precise dose titration workflows
- Mini-Heart Platform: Architects a modular tri-format system derived from human stem cell cardiomyocytes to quantify cardiac functional outputs and support pre-clinical and clinical trial assessments
- Human Heart-in-a-Jar (hvCOC): Builds a bioengineered 'novoHeart' ventricular organoid chamber to assess drug toxicity and efficacy, with pump-enabled fluid ejection mimicking ventricular function
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Novoheart
SAW Instruments
HQ: Germany
Website
- Description: Provider of innovative analytical systems for the life sciences market, enabling label-free analysis of molecular biomolecular interactions and combining stability, ease of use, and high sensitivity; develops, manufactures, and sells equipment for life sciences applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SAW Instruments company profile →
Bio Products Laboratory
HQ: United States
Website
- Description: Provider of plasma collection and plasma-derived medicines, headquartered in the UK and delivering life-saving treatments worldwide for immune deficiencies, bleeding disorders, infectious diseases, and critical care. Operates 29 US donor centers and supplies human albumin (approved for the Chinese market), plus immunology, critical care, and coagulation disorder products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio Products Laboratory company profile →
Synple Chem
HQ: Switzerland
Website
- Description: Provider of automated reagent cartridge-based synthesizers and reaction kits for chemical laboratories such as drug discovery laboratories, enabling molecule synthesis with minimal user involvement. Offerings include Synple 2, Synple Unity, Synple Reaction Kits, and cartridges for N-heterocycles, reductive amination, and Mitsunobu reactions; usable with automated liquid handlers or manual pipettes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synple Chem company profile →
Gemini Bio
HQ: United States
Website
- Description: Provider of FDA-registered biological products and chemical reagents for the global cell culture community, offering cell culture sera (fetal bovine and other human/animal), custom and specialized media and buffers, supplements and reagents (amino acids, antibiotics, antimycotics), high purity water including WFI-quality, and cGMP contract manufacturing/private-label process liquids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gemini Bio company profile →
Expedeon
HQ: United States
Website
- Description: Provider of cutting-edge innovative reagents and services for life sciences and diagnostics, with applications across workflows including protein electrophoresis, liquid biopsy, whole genome amplification, antibody- and protein-labeling, and immunoassay development; offering off-the-shelf products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Expedeon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Novoheart
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Novoheart
2.2 - Growth funds investing in similar companies to Novoheart
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Novoheart
4.2 - Public trading comparable groups for Novoheart
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →